Elizabeth Holmes, once celebrated as the world’s youngest self-made female billionaire, is now serving an 11-year prison sentence for defrauding investors in her blood-testing startup, Theranos. In May 2025, the 9th U.S. Circuit Court of Appeals dealt her what may be the final legal blow, denying her bid to have her 2022 conviction reheard.
In a decisive ruling, the U.S. Court of Appeals for the Ninth Circuit has upheld the conviction of Theranos founder Elizabeth Holmes, rejecting her appeal against multiple fraud charges linked to her now-defunct blood-testing startup. Holmes, who is currently serving a nine-year prison sentence, had sought to overturn her conviction on the grounds of alleged legal errors during her trial.
The culture of embellishment that once permeated Silicon Valley has caught up with another tech entrepreneur. Manish Lachwani, the founder of the software startup HeadSpin, has been sentenced to 18 months in prison for fraudulently inflating his company’s financial health to secure investments. This case, detailed in a recent New York Times article, underscores a growing trend of legal accountability for deceptive practices in the startup sector.
In California, a federal jury found Elizabeth Holmes, the Theranos founder, guilty of investment fraud. She was charged with nine counts of wire fraud, and two counts of conspiracy to commit wire fraud under an indictment brought 3 ½ years ago. The jury convicted her on four of 11 charges of investment fraud. Each count carries a maximum prison sentence of 20 years. However, the 12 jurors failed to reach a verdict on three counts related to investors and were found not guilty of four charges relating to defrauding the public.